17β-Estradiol protects lymphocytes against dopamine and iron-induced apoptosis by a genomic-independent mechanism - Implication in Parkinson's disease

General Pharmacology: The Vascular System

Volumn 35, Issue 1, 2000, Pages 1-9

  Jimenez Del Rio, M ^a   Velez Pardo, C ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; FERROUS ION; HYDROGEN PEROXIDE; PEROXIDE; PROTEIN; RNA;

ADULT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL DEATH; CELL PROTECTION; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; NERVE CELL; NORMAL HUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS;

EID: 0034783410     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(01)00082-9     Document Type: Article

References (81)

1. Dopamine D2-like receptors on human peripheral blood lymphocytes: A radioligand binding assay and immunocytochemical study
2. Increased expression of dopamine receptors on lymphocytes in Parkinson's disease
3. Estrogens with an intact phenolic group prevent death of neuronal cells following glutathione depletion
4. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro
5. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship
6. Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats
7. p53 and Bax activation in 6-hydroxydopamine induce apoptosis in PC12 cells
8. Norepinephrine transmitter metabolite induces apoptosis in differentiated rat pheochromocytoma cells
9. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents
10. Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionising radiation
11. Estrogen decreases corpus striata neurotoxicity in response to 6-hydroxydopamine
12. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia
13. Estradiol: A protective and trophic factor in the brain
14. Prospects for new restorative and neuroprotective treatments in Parkinson's disease
15. The protective effects of estrogen on the cardiovascular system
16. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
17. Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines
18. Neuropathology of Parkinson's disease
19. Altered brain metabolism of iron as a cause of degenerative disease?
20. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
21. Reactive oxygen species and the central nervous system
22. Vitamin C: Poison, prophylactic or panacea?
23. The chemistry of oxygen radicals and other oxygen derived species
24. Dual regulation of caspase activity by hydrogen peroxide: Implication for apoptosis
25. 3H]-dopamine: Impact of ascorbic acid and glutathione
26. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections
27. Iron metabolism and Parkinson's disease
28. Steroid hormones and bone
29. Novel drugs for Parkinson's disease
30. Covalent binding of catechols to proteins through sulphydryl group
31. Oxidative mechanism in nigral cell death in Parkinson's disease
32. Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders
33. Molecular mechanism of monoamine toxicity in Parkinson's disease: Hypothetical cell death model
34. Binding of serotonin and dopamine to 'serotonin binding proteins' in bovine frontal cortex: Evidence for iron-induced oxidative mechanisms
35. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis
36. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes
37. Catecholamine metabolism: Basic aspects and clinical significance
38. p21-ras as a common signaling target of reactive free radicals and cellular redox stress
39. Hydrogen peroxide suppresses U937 cell death by two different mechanisms depending on its concentration
40. Mature lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment
41. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway
42. Micromolar zinc affects endonucleolytic activity in hydrogen peroxide-mediated apoptosis
43. Apoptosis: Suicide, murder or execution?
44. The end of (cell) line: Methods for the study of apoptosis in vitro
45. Protective effects of estrogen on the cardiovascular system
46. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture
47. Toxic and protective effects of L-DOPA on mesencephalic cell cultures
48. Steroid hormone receptors in normal human lymphocytes
49. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation
50. Prevention of dopamine induced cell death by thiol antioxidant: Possible implications for treatment of Parkinson's disease
51. Metals and free radicals in neurodegeneration
52. Etiology and pathogenesis of Parkinson's disease
53. Iron and neurodegeneration: Prospects for neuroprotection
54. Estrogen modulates neuronal BcL-xL expression and β-amyloid induced apoptosis: Relevance to Alzheimer's disease
55. The central effectors of cell death in the immune system
56. Dopamine D5 receptors in human peripheral blood lymphocytes: A radioligand binding study
57. 3H} 7OH-DPAT
58. Dopamine D4 receptor in human peripheral blood lymphocytes: A radioligand binding assay study
59. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with 1-deprenyl
60. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
61. Flow cytometric assays of oxidative burst activity phagocytes
62. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress induced neuronal death
63. Iron induced neurodegeneration of nigrostriatal neurons
64. Cholinergic muscarinic binding by rat lymphocytes: Effects of antagonist treatment, strain an aging
65. Neuroprotective therapies
66. Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus
67. Endometrial leucocytes: Expression of steroid hormone receptors
68. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease
69. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons
70. 6-Hydroxydopamine induces thymocyte apoptosis in mice
71. 2+-mediated binding of serotonin and dopamine to skeletal muscle actin: Resemblance to serotonin binding proteins
72. Redox cycling activity of monoamine-"serotonin binding protein" conjugates
73. Dopamine and iron induce apoptosis in PC12 cells
74. Monoamine and iron-related toxicity: From "serotonin binding proteins" to lipid peroxidation and apoptosis in PC12 cells
75. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis
76. Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implication for the treatment of Parkinson's disease
77. Toxicity of iron and hydrogen peroxide: The Fenton reaction
78. Genes and parkinsonism
79. Effects of estrogen in the CNS
80. Glucocorticoid-induced thymocytes apoptosis associated with endogenous endonuclease activation
81. Monoamine-induced apoptotic neuronal cell death